Ambe, Wilma A.

HRN: 24-03-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/03/2023
11/11/2023
IV
600mg
QID
DM Foot
Checking Final Appropriateness 
11/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/05/2023
11/12/2023
IV
1.5gm
TID
Infected Wound
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: